"
Team:BostonU/Backbones
From 2014.igem.org
(Difference between revisions)
| Line 13: | Line 13: | ||
<table width="100%" border="0" cellspacing="0" cellpadding="0"> | <table width="100%" border="0" cellspacing="0" cellpadding="0"> | ||
<tr> | <tr> | ||
| - | <th colspan="2" scope="col">The work carried out by previous BU iGEM teams used destination vectors, or plasmid backbones, with high copy origins of replication. These high-copy plasmids in our library would not allow for optimal performance of our multiplexed transcriptional units and larger constructs. Additionally, works upon which we are basing our complex circuit assembly do not use high copy origins in their devices for the same reason. Circuit behavior would be desynchronized with the presence of a high copy origin, as it causes overexpression of the plasmid in a cell, leading to a high amount of transcription and protein expression. For more complex circuits, this overexpression pushes the limit of the amount of ribosomes that can be sequestered for translation, in addition to straining the cell's protein degradation mechanisms. This notebook details the process undertaken to replace the high copy pMB1 origin in our existing Level 1 and Level 2 destination vectors (named DVL1 and DVL2, respectively) with lower copy origins. Namely, the ColE1 (~50 plasmids/cell), p15A (~10 plasmids/cell), and pSC101 (~5 plasmids/cell) origins were selected to replace the high copy origin in DVL1 and DVL2.</th> | + | <th colspan="2" scope="col">The work carried out by previous BU iGEM teams used destination vectors, or plasmid backbones, with high copy origins of replication. These high-copy plasmids in our library would not allow for optimal performance of our multiplexed transcriptional units and larger constructs. Additionally, works upon which we are basing our complex circuit assembly do not use high copy origins in their devices for the same reason. Circuit behavior would be desynchronized with the presence of a high copy origin, as it causes overexpression of the plasmid in a cell, leading to a high amount of transcription and protein expression. For more complex circuits, this overexpression pushes the limit of the amount of ribosomes that can be sequestered for translation, in addition to straining the cell's protein degradation mechanisms. <br><br>This notebook details the process undertaken to replace the high copy pMB1 origin in our existing Level 1 and Level 2 destination vectors (named DVL1 and DVL2, respectively) with lower copy origins. Namely, the ColE1 (~50 plasmids/cell), p15A (~10 plasmids/cell), and pSC101 (~5 plasmids/cell) origins were selected to replace the high copy origin in DVL1 and DVL2.</th> |
</tr> | </tr> | ||
<br> | <br> | ||
<tr> | <tr> | ||
| - | <th colspan="2" scope="col"><h2>June</h2></th> | + | <th colspan="2" scope="col"><br><h2>June</h2></th> |
</tr> | </tr> | ||
Revision as of 14:54, 10 July 2014
| The work carried out by previous BU iGEM teams used destination vectors, or plasmid backbones, with high copy origins of replication. These high-copy plasmids in our library would not allow for optimal performance of our multiplexed transcriptional units and larger constructs. Additionally, works upon which we are basing our complex circuit assembly do not use high copy origins in their devices for the same reason. Circuit behavior would be desynchronized with the presence of a high copy origin, as it causes overexpression of the plasmid in a cell, leading to a high amount of transcription and protein expression. For more complex circuits, this overexpression pushes the limit of the amount of ribosomes that can be sequestered for translation, in addition to straining the cell's protein degradation mechanisms. This notebook details the process undertaken to replace the high copy pMB1 origin in our existing Level 1 and Level 2 destination vectors (named DVL1 and DVL2, respectively) with lower copy origins. Namely, the ColE1 (~50 plasmids/cell), p15A (~10 plasmids/cell), and pSC101 (~5 plasmids/cell) origins were selected to replace the high copy origin in DVL1 and DVL2. |
|
|---|---|
June |
|
Week of June 23 |
|
| • Learned about synthetic biology, iGEM, and MoClo. • Became familiar with lab part and BioBrick part nomenclature. • Learned how to use miniEugene from CIDAR lab members. • Developed plan for next two weeks that would guide through training of essential lab protocols - specifically plate streaking, minipreps, MoClo, sequencing, and colony PCR. • Began using miniEugene to design architecture of constructs. • Struck out plates with 15 L0 parts, 6 L1 parts, and 2 L2 parts and grew colonies in liquid cultures overnight. |
|
Week of May 19 |
|
| • Performed minipreps and quantified the DNA concentration of parts using a Nanodrop spectrophotometer. • Sent the parts for sequencing, all but four of which were correctly verified using BLAST. Parts not correctly verified were re-submitted for sequencing. • Transformed verified parts into E. Coli Bioline cells and performed colony PCR and gel electrophoresis. |
|
Week of May 26 | |
| • Analyzed gels and picked colonies. • Performed minipreps on gel-verified strains. • Made glycerol stocks of confirmed parts. • Set up and performed MoClo reactions to make 2 new L1 parts. • Transformed MoClo reactions and grew up over the weekend. |
|
June | |
Week of June 2 | |
| • Picked colonies, miniprepped, quantifies, and sent parts for sequence verification. • Set up and performed MoClo reaction for 2 new L1 and 2 new L2 parts. • Transformed reactions and grew up overnight. • Brainstormed to further define project goals. |
|
Week of June 9 | |
| • Participated in SB2 (Synthetic Biology Boston) and IWBDA (Internatonal Workshop on Bio-Design Automation) workshops hosted at BU. | |
Week of June 16 | |
| • Set up parts for FACS experiment. • Participated in NEGEM meetup. |
